Insider · CIK 0001221599

ASELAGE STEVE

Reports to the SEC for 6 companies · NOVATO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001221599

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-12	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+49.9K sh	—	—	49,933
2024-06-12	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+6,820 sh	—	—	70,159
2024-05-24	BCRXBIOCRYST PHARMACEUTICALS INCP Purchase	Director	PPurchase	+2,500 sh	$6.40	+$16K	2,500
2023-11-17	Acer Therapeutics Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−484K sh	—	—	0
2023-06-13	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+39.1K sh	—	—	39,072
2023-06-13	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+16.7K sh	—	—	63,339
2023-03-14	Acer Therapeutics Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-11-29	Acer Therapeutics Inc.P Purchase	Director	PPurchase	+410K sh	$1.22	+$500K	483,741
2022-06-07	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+30K sh	—	—	30,022
2022-06-07	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+12.9K sh	—	—	46,594
2022-05-31	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+569 sh	$9.31	+$5,297.39	33,728
2022-05-11	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−2,575 sh	$21.92	−$56.5K	146,919
2022-02-28	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+301 sh	$16.61	+$4,999.61	33,159
2022-01-14	Acer Therapeutics Inc.Stock Option (right to buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2021-12-10	Acer Therapeutics Inc.P Purchase	Director	PPurchase	+7,984 sh	$2.04	+$16.3K	73,905
2021-12-09	Acer Therapeutics Inc.P Purchase	Director	PPurchase	+2,016 sh	$2.15	+$4,334.4	65,921
2021-11-30	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+414 sh	$12.06	+$4,992.84	32,858
2021-11-16	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−31.8K sh	$29.39	−$935K	149,494
2021-11-05	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$26.23	−$262K	161,794
2021-11-05	TVTXTravere Therapeutics, Inc. · Employee stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	70,000
2021-11-05	TVTXTravere Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$16.23	+$162K	171,794
2021-11-02	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−3,500 sh	$30.00	−$105K	19,500
2021-11-01	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−5,000 sh	$29.48	−$147K	23,000
2021-10-07	TVTXTravere Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+60K sh	$16.23	+$974K	249,794
2021-10-07	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−28K sh	$26.23	−$734K	221,794
2021-10-07	TVTXTravere Therapeutics, Inc. · Employee stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−60K sh	—	—	80,000
2021-10-07	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−32K sh	$26.26	−$840K	189,794
2021-08-31	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+314 sh	$15.92	+$4,998.88	32,444
2021-07-16	TVTXTravere Therapeutics, Inc.G Gift	Director	GGift	−3,000 sh	—	—	161,794
2021-07-16	TVTXTravere Therapeutics, Inc.G Gift	Director	GGift	+3,000 sh	—	—	28,000
2021-05-28	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+634 sh	$15.77	+$9,998.18	32,130
2021-05-25	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+40K sh	—	—	40,000
2021-05-14	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2021-05-14	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+3,000 sh	—	—	189,794
2021-05-11	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−2,146 sh	$19.58	−$42K	186,794
2021-04-16	TVTXTravere Therapeutics, Inc. · Employee stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	140,000
2021-04-16	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$26.23	−$262K	188,940
2021-04-16	TVTXTravere Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$16.23	+$162K	198,940
2021-03-17	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$27.35	−$274K	196,667
2021-03-17	TVTXTravere Therapeutics, Inc. · Employee stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	150,000
2021-03-17	TVTXTravere Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$16.23	+$162K	206,667
2021-03-17	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−7,727 sh	$27.56	−$213K	188,940
2021-02-26	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+927 sh	$10.78	+$9,993.06	31,496
2021-02-21	TVTXTravere Therapeutics, Inc. · Employee stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	275,000
2021-02-04	TVTXTravere Therapeutics, Inc.G Gift	Director	GGift	−25K sh	—	—	164,794
2021-02-04	TVTXTravere Therapeutics, Inc.G Gift	Director	GGift	+25K sh	—	—	25,000
2021-02-02	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−25K sh	$30.75	−$769K	196,667
2021-02-02	TVTXTravere Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$10.09	+$252K	221,667
2021-01-15	Acer Therapeutics Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-12-15	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−5,549 sh	$26.02	−$144K	196,667

Recent filings

Accepted (ET)
Jun 144
ASELAGE STEVE0001127602-24-018708
SEC(opens sec.gov)
May 294
ASELAGE STEVE0001127602-24-016776
SEC(opens sec.gov)
Nov 204
ASELAGE STEVE0000899243-23-020445
SEC(opens sec.gov)
Jun 154
ASELAGE STEVE0001127602-23-018786
SEC(opens sec.gov)
Mar 164
ASELAGE STEVE0001209191-23-019300
SEC(opens sec.gov)
Dec 14
ASELAGE STEVE0001209191-22-059172
SEC(opens sec.gov)
Jun 94
ASELAGE STEVE0001127602-22-017138
SEC(opens sec.gov)
Jun 24
ASELAGE STEVE0001127602-22-016409
SEC(opens sec.gov)
May 124
ASELAGE STEVE0001209191-22-028702
SEC(opens sec.gov)
Mar 24
ASELAGE STEVE0001127602-22-007717
SEC(opens sec.gov)
Jan 194
ASELAGE STEVE0001209191-22-003708
SEC(opens sec.gov)
Dec 134
ASELAGE STEVE0001209191-21-069227
SEC(opens sec.gov)
Dec 24
ASELAGE STEVE0001127602-21-030063
SEC(opens sec.gov)
Nov 184
ASELAGE STEVE0001209191-21-065439
SEC(opens sec.gov)
Nov 94
ASELAGE STEVE0001209191-21-063591
SEC(opens sec.gov)

Companies

Address

C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE

NOVATO, CA, 94949